Evolving Strategies Using BTK Inhibitors in CLL: A Selective Approach to Improve Patient Outcomes

Hear from the experts on how the latest clinical data inform the use of BTK inhibitors in the treatment of CLL. Review their insights in an on-demand webcast adapted from a live webinar along with downloadable slidesets 2 commentaries and a podcast.

Share

Program Content

Activities

BTK inhibitors in CLL
Evolving Strategies Using BTK Inhibitors in CLL: A Selective Approach to Improve Patient Outcomes
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2021

Expires: July 18, 2022

Activities

EHA: BTKi combinations
EHA 2021: BTK Inhibitor-Based Combinations in Frontline CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2021

Expires: June 10, 2022

EHA: BTKi in CLL
EHA 2021: The Current Role of BTK Inhibitors in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2021

Expires: June 10, 2022

EHA: Safety of BTKi in CLL
EHA 2021: A Focus on Safety of BTK inhibitors in the Management of CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2021

Expires: June 10, 2022

ICML: BTKi in CLL
ICML 2021: The Current Role of BTK Inhibitors in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 21, 2021

Expires: June 20, 2022

ICML: Safety of BTKi in CLL
ICML 2021: A Focus on Safety of BTK inhibitors in the Management of CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 22, 2021

Expires: June 21, 2022

ICML: BTKi combinations
ICML 2021: BTK Inhibitor-Based Combinations in Frontline CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 22, 2021

Expires: June 21, 2022

<i>EP</i>: BTKi Strategies in CLL
ExpressPoints
Evolving Strategies Using BTK Inhibitors in CLL: A Selective Approach to Improve Patient Outcomes
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2021

Expires: June 22, 2022

Activities

ASCO/EHA/ICML 2021: CLL Data
Expert Perspective on Key Trial Updates in Treatment of CLL: What You Need to Know From ASCO/EHA/ICML 2021
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2021

Expires: September 16, 2022

Faculty

cover img faculity

George Follows, BM, BCh, PhD

Visiting Professor of Haematology
Department of Haematology
Anglia Ruskin Medical School
Consultant Haematologist
Department of Haematology
Cambridge University Hospitals
Cambridge, United Kingdom

cover img faculity

Paolo Ghia, MD, PhD

Professor of Medical Oncology
Division of Experimental Oncology
Università Vita-Salute San Raffaele
Milan, Italy

cover img faculity

Veronique Leblond, MD

Professor, Hematology
Sorbonne University
Head, Department of Hematology
Pitié Salpêtrière Hospital
Paris, France

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca